Eric M. Dube - 01 Jun 2021 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Issuer symbol
TVTX
Transactions as of
01 Jun 2021
Net transactions value
-$139,797
Form type
4
Filing time
03 Jun 2021, 16:07:27 UTC
Next filing
17 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale $71,204 -4,782 -3% $14.89 152,031 01 Jun 2021 Direct F1
transaction TVTX Common Stock Sale $68,593 -4,780 -3.1% $14.35 147,251 02 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were made pursuant to a written plan adopted on June 15, 2020 and meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.